ARTICLE | Company News
Oxford GlycoSciences, Pfizer deal
January 2, 2001 8:00 AM UTC
The companies will extend their 1998 collaboration to use OGS's proteomics technology to discover biomarkers and drug targets for Alzheimer's disease and atherosclerosis (see BioCentury, April 13, 199...